MeiraGTx Holdings plc

MGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $65.9M $103.7M $129.6M $115.5M $137.7M $209.5M $227.2M $68.1M
Accounts Receivable $3.0M $707.0K $10.1M $21.3M — — — —
Inventory — $385.0K — — — — — —
Total Current Assets $91.8M $123.5M $159.6M $154.3M $183.2M $272.6M $269.0M $74.7M
Property, Plant & Equipment $105.5M $102.9M $115.9M $109.3M $75.9M $44.0M $23.9M $22.0M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $578.0K $821.0K $1.1M $1.3M $1.8M $2.1M $0 —
Total Assets $244.4M $269.8M $326.7M $318.2M $320.2M $363.7M $323.9M $96.9M
Liabilities
Accounts Payable $10.1M $23.6M $16.0M $16.6M $15.3M $7.1M $3.8M $3.0M
Total Current Liabilities $122.6M $60.8M $67.1M $82.1M $68.1M $54.1M $49.2M $15.5M
Long-Term Debt — — — — — — — —
Total Liabilities $250.2M $201.9M $188.6M $200.5M $134.8M $125.1M $133.1M $15.8M
Stockholders' Equity
Retained Earnings $-816.2M $-702.0M $-554.2M $-470.2M $-340.6M $-261.0M $-203.0M $-148.3M
Total Stockholders' Equity $-5.8M $67.8M $138.2M $117.7M $185.4M $238.6M $190.8M $81.1M
← Newer Page 1 of 2 Older →